Company Update (NASDAQ:GILD): Gilead Sciences to Present at the Cowen & Company 36th Annual Health Care Conference on Monday, March 7

[Business Wire] – Gilead Sciences, Inc. today announced that its corporate presentation will be webcast from the Cowen and Company 36th Annual Health Care Conference in Boston. Read more on this. Gilead Sciences Inc. (GILD) , currently valued at $124.01B, started the session at $88.30. Looking at the stock, its one day range is $86.85 to $89.10 with a one year range of $81.89 to $123.37. Gilead (GILD) shares are currently priced at 7.20x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 1.14x earnings multiple for the same period. The company pays shareholders $1.72 per share annually in dividends, yielding 1.92%. In a review of the consensus earnings estimate this quarter, 21 sell-side analysts are looking at $3.09 per share, which would be $0.15 better than the year-ago quarter and a $0.19 sequential increase. The full-year EPS estimate is $12.20, which would be a $0.41 better than last year. The quarterly earnings estimate is predicated on a consensus revenue forecast of $7.98 Billion. If reported, that would be a 5.14% increase over the year-ago quarter. Recently, Citigroup Initiated GILD at Buy (Feb 25, 2016). Previously, Standpoint Research Initiated GILD at to Buy. The average price target for GILD shares is $115.60, which is 30.92% above where the stock opened this morning. See more in (NASDAQ:GILD) Similar Articles: Market Update: Gilead Sciences Inc (NASDAQ:GILD) – Health Canada Issues Notice of Compliance for Gilead’s Truvada® for Reducing the Risk of Sexually Acquired HIV Infection Company Update (NASDAQ:GILD): Gilead Sciences to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11 Market Update (NASDAQ:GILD): Gilead Sciences to Present at the Credit Suisse 24th Annual Healthcare Conference on Tuesday, November 10